DarioHealth Corp. (DRIO) stock
DRIONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 8/3099% below fair value
$1.15−0.11 (-8.73%)
Close on Nov 16, 2026Market cap $11.27MP/E 0.3Yield –
DarioHealth r&d expenses
Research and development expenses are spending on new products and technology.
DarioHealth's R&D Expenses for the twelve months ending Jun 30, 2026 was $10.45M, down 43.7% year over year. For fiscal 2025 it was $13.79M, down 43.0% from the year before. Over ten years it grew 18.3% a year on average. The highest annual figure on record is $24.18M in fiscal 2024.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $13.79M | -43.0% |
| FY2024 | Dec 31, 2024 | $24.18M | +19.4% |
| FY2023 | Dec 31, 2023 | $20.25M | +3.0% |
| FY2022 | Dec 31, 2022 | $19.65M | +14.1% |
| FY2021 | Dec 31, 2021 | $17.22M | +288.4% |
| FY2020 | Dec 31, 2020 | $4.43M | +20.1% |
| FY2019 | Dec 31, 2019 | $3.69M | +0.4% |
| FY2018 | Dec 31, 2018 | $3.68M | +11.5% |
| FY2017 | Dec 31, 2017 | $3.30M | +53.1% |
| FY2016 | Dec 31, 2016 | $2.15M | -16.0% |
| FY2015 | Dec 31, 2015 | $2.57M | -34.9% |
| FY2014 | Dec 31, 2014 | $3.94M | -19.7% |
| FY2013 | Dec 31, 2013 | $4.91M | +227.2% |
| FY2012 | Dec 31, 2012 | $1.50M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $2.10M | -43.6% |
| Q1 FY2026 | Mar 31, 2026 | $2.39M | -41.9% |
| Q4 FY2025 | Dec 31, 2025 | $2.63M | -50.1% |
| Q3 FY2025 | Sep 30, 2025 | $3.33M | -38.9% |
| Q2 FY2025 | Jun 30, 2025 | $3.72M | -45.4% |
| Q1 FY2025 | Mar 31, 2025 | $4.11M | -38.2% |
| Q4 FY2024 | Dec 31, 2024 | $5.28M | +25.9% |
| Q3 FY2024 | Sep 30, 2024 | $5.45M | -3.9% |
| Q2 FY2024 | Jun 30, 2024 | $6.81M | +30.4% |
| Q1 FY2024 | Mar 31, 2024 | $6.64M | +28.6% |
| Q4 FY2023 | Dec 31, 2023 | $4.20M | -12.3% |
| Q3 FY2023 | Sep 30, 2023 | $5.67M | +17.9% |
| Q2 FY2023 | Jun 30, 2023 | $5.22M | +26.2% |
| Q1 FY2023 | Mar 31, 2023 | $5.17M | -12.9% |
| Q4 FY2022 | Dec 31, 2022 | $4.78M | -10.0% |
| Q3 FY2022 | Sep 30, 2022 | $4.80M | -12.8% |
| Q2 FY2022 | Jun 30, 2022 | $4.14M | +10.6% |
| Q1 FY2022 | Mar 31, 2022 | $5.93M | +123.2% |
| Q4 FY2021 | Dec 31, 2021 | $5.32M | +273.6% |
| Q3 FY2021 | Sep 30, 2021 | $5.51M | +477.1% |
| Q2 FY2021 | Jun 30, 2021 | $3.74M | +353.6% |
| Q1 FY2021 | Mar 31, 2021 | $2.66M | +115.7% |
| Q4 FY2020 | Dec 31, 2020 | $1.42M | +69.4% |
| Q3 FY2020 | Sep 30, 2020 | $954.00K | +11.1% |
| Q2 FY2020 | Jun 30, 2020 | $825.00K | -16.8% |
| Q1 FY2020 | Mar 31, 2020 | $1.23M | +22.9% |
| Q4 FY2019 | Dec 31, 2019 | $840.00K | -9.4% |
| Q3 FY2019 | Sep 30, 2019 | $859.00K | -13.8% |
| Q2 FY2019 | Jun 30, 2019 | $991.00K | -1.9% |
| Q1 FY2019 | Mar 31, 2019 | $1.00M | +35.0% |
| Q4 FY2018 | Dec 31, 2018 | $927.00K | +9.4% |
| Q3 FY2018 | Sep 30, 2018 | $997.00K | +25.1% |
| Q2 FY2018 | Jun 30, 2018 | $1.01M | -14.7% |
| Q1 FY2018 | Mar 31, 2018 | $742.00K | +58.2% |
| Q4 FY2017 | Dec 31, 2017 | $847.00K | +46.8% |
| Q3 FY2017 | Sep 30, 2017 | $797.00K | +20.9% |
| Q2 FY2017 | Jun 30, 2017 | $1.18M | – |
| Q1 FY2017 | Mar 31, 2017 | $469.00K | – |
| Q4 FY2016 | Dec 31, 2016 | $577.00K | – |
| Q3 FY2016 | Sep 30, 2016 | $659.00K | – |
See a number that looks wrong?